DTC Ads Must Be "Clear And Balanced" Under Sen. Edwards Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The legislation is similar to an amendment Edwards proposed for the Medicare Rx bill. It also calls for NIH comparative efficacy studies and an expedited drug advertisement review process.
You may also be interested in...
Democratic VP Nominee Edwards Bolsters Kerry’s “Affordable Health Care” Agenda
Sen. Edwards is an advocate of stricter DTC regulation, generic patent law reform, comparative effectiveness research and DoJ investigation of manufacturer “price gouging.”
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.